nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurbiprofen—PTGS2—atherosclerosis	0.126	0.529	CbGaD
Flurbiprofen—ALB—atherosclerosis	0.112	0.471	CbGaD
Flurbiprofen—UGT1A3—Ezetimibe—atherosclerosis	0.0677	0.121	CbGbCtD
Flurbiprofen—UGT1A3—Simvastatin—atherosclerosis	0.0629	0.112	CbGbCtD
Flurbiprofen—UGT1A3—Lovastatin—atherosclerosis	0.0616	0.11	CbGbCtD
Flurbiprofen—UGT2B7—Ezetimibe—atherosclerosis	0.0489	0.0874	CbGbCtD
Flurbiprofen—UGT2B7—Simvastatin—atherosclerosis	0.0455	0.0812	CbGbCtD
Flurbiprofen—UGT2B7—Lovastatin—atherosclerosis	0.0445	0.0795	CbGbCtD
Flurbiprofen—ABCC4—Rosuvastatin—atherosclerosis	0.0432	0.0772	CbGbCtD
Flurbiprofen—UGT1A1—Ezetimibe—atherosclerosis	0.0423	0.0755	CbGbCtD
Flurbiprofen—UGT1A1—Simvastatin—atherosclerosis	0.0393	0.0702	CbGbCtD
Flurbiprofen—UGT1A1—Lovastatin—atherosclerosis	0.0385	0.0687	CbGbCtD
Flurbiprofen—SLC22A6—Pravastatin—atherosclerosis	0.0171	0.0306	CbGbCtD
Flurbiprofen—ALB—Rosuvastatin—atherosclerosis	0.016	0.0286	CbGbCtD
Flurbiprofen—CYP2C9—Rosuvastatin—atherosclerosis	0.00864	0.0154	CbGbCtD
Flurbiprofen—CYP2C9—Simvastatin—atherosclerosis	0.00803	0.0143	CbGbCtD
Flurbiprofen—CYP2C9—Lovastatin—atherosclerosis	0.00786	0.014	CbGbCtD
Flurbiprofen—CYP2C9—Pravastatin—atherosclerosis	0.00786	0.014	CbGbCtD
Flurbiprofen—UGT2B4—cardiovascular system—atherosclerosis	0.001	0.0956	CbGeAlD
Flurbiprofen—PTGS2—leg—atherosclerosis	0.000905	0.0863	CbGeAlD
Flurbiprofen—PTGS2—hindlimb—atherosclerosis	0.000808	0.0771	CbGeAlD
Flurbiprofen—PTGS2—appendage—atherosclerosis	0.000693	0.0661	CbGeAlD
Flurbiprofen—UGT2B4—liver—atherosclerosis	0.00062	0.0591	CbGeAlD
Flurbiprofen—Ibuprofen—THBD—atherosclerosis	0.000604	0.182	CrCbGaD
Flurbiprofen—UGT1A3—liver—atherosclerosis	0.000594	0.0567	CbGeAlD
Flurbiprofen—PTGS1—artery—atherosclerosis	0.000518	0.0494	CbGeAlD
Flurbiprofen—PTGS2—artery—atherosclerosis	0.000495	0.0473	CbGeAlD
Flurbiprofen—PTGS1—endothelium—atherosclerosis	0.000438	0.0418	CbGeAlD
Flurbiprofen—UGT1A9—liver—atherosclerosis	0.000423	0.0404	CbGeAlD
Flurbiprofen—PTGS2—endothelium—atherosclerosis	0.000418	0.0399	CbGeAlD
Flurbiprofen—Ibuprofen—PLAT—atherosclerosis	0.000414	0.125	CrCbGaD
Flurbiprofen—PTGS1—blood vessel—atherosclerosis	0.000404	0.0385	CbGeAlD
Flurbiprofen—PTGS2—blood vessel—atherosclerosis	0.000386	0.0368	CbGeAlD
Flurbiprofen—UGT2B7—liver—atherosclerosis	0.000341	0.0326	CbGeAlD
Flurbiprofen—UGT1A1—liver—atherosclerosis	0.00029	0.0277	CbGeAlD
Flurbiprofen—ABCC4—adipose tissue—atherosclerosis	0.00027	0.0257	CbGeAlD
Flurbiprofen—Sinusitis—Pravastatin—atherosclerosis	0.000233	0.00213	CcSEcCtD
Flurbiprofen—Alopecia—Lovastatin—atherosclerosis	0.000233	0.00213	CcSEcCtD
Flurbiprofen—Myalgia—Rosuvastatin—atherosclerosis	0.000231	0.0021	CcSEcCtD
Flurbiprofen—Alopecia—Ezetimibe—atherosclerosis	0.000229	0.00209	CcSEcCtD
Flurbiprofen—Haemoglobin—Niacin—atherosclerosis	0.000228	0.00208	CcSEcCtD
Flurbiprofen—Rhinitis—Niacin—atherosclerosis	0.000227	0.00207	CcSEcCtD
Flurbiprofen—Haemorrhage—Niacin—atherosclerosis	0.000227	0.00207	CcSEcCtD
Flurbiprofen—Hepatitis—Niacin—atherosclerosis	0.000227	0.00207	CcSEcCtD
Flurbiprofen—Flatulence—Lovastatin—atherosclerosis	0.000226	0.00206	CcSEcCtD
Flurbiprofen—Rhinitis—Pravastatin—atherosclerosis	0.000224	0.00204	CcSEcCtD
Flurbiprofen—Hepatitis—Pravastatin—atherosclerosis	0.000223	0.00204	CcSEcCtD
Flurbiprofen—Confusional state—Rosuvastatin—atherosclerosis	0.000223	0.00203	CcSEcCtD
Flurbiprofen—Flatulence—Ezetimibe—atherosclerosis	0.000222	0.00202	CcSEcCtD
Flurbiprofen—Pharyngitis—Pravastatin—atherosclerosis	0.000222	0.00202	CcSEcCtD
Flurbiprofen—Chills—Simvastatin—atherosclerosis	0.000222	0.00202	CcSEcCtD
Flurbiprofen—Infection—Rosuvastatin—atherosclerosis	0.00022	0.002	CcSEcCtD
Flurbiprofen—Visual impairment—Niacin—atherosclerosis	0.000218	0.00199	CcSEcCtD
Flurbiprofen—Alopecia—Simvastatin—atherosclerosis	0.000218	0.00199	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000217	0.00198	CcSEcCtD
Flurbiprofen—Tremor—Lovastatin—atherosclerosis	0.000215	0.00196	CcSEcCtD
Flurbiprofen—Visual impairment—Pravastatin—atherosclerosis	0.000215	0.00196	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Lovastatin—atherosclerosis	0.000213	0.00194	CcSEcCtD
Flurbiprofen—Flatulence—Simvastatin—atherosclerosis	0.000212	0.00193	CcSEcCtD
Flurbiprofen—Tinnitus—Niacin—atherosclerosis	0.000211	0.00193	CcSEcCtD
Flurbiprofen—Erythema multiforme—Pravastatin—atherosclerosis	0.000211	0.00192	CcSEcCtD
Flurbiprofen—Angioedema—Lovastatin—atherosclerosis	0.00021	0.00191	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000209	0.00191	CcSEcCtD
Flurbiprofen—Anaemia—Ezetimibe—atherosclerosis	0.000208	0.0019	CcSEcCtD
Flurbiprofen—Tinnitus—Pravastatin—atherosclerosis	0.000208	0.0019	CcSEcCtD
Flurbiprofen—Malaise—Lovastatin—atherosclerosis	0.000207	0.00189	CcSEcCtD
Flurbiprofen—PTGS1—connective tissue—atherosclerosis	0.000207	0.0197	CbGeAlD
Flurbiprofen—Vertigo—Lovastatin—atherosclerosis	0.000206	0.00188	CcSEcCtD
Flurbiprofen—Angioedema—Ezetimibe—atherosclerosis	0.000206	0.00188	CcSEcCtD
Flurbiprofen—Angiopathy—Niacin—atherosclerosis	0.000206	0.00188	CcSEcCtD
Flurbiprofen—Leukopenia—Lovastatin—atherosclerosis	0.000206	0.00188	CcSEcCtD
Flurbiprofen—Chills—Niacin—atherosclerosis	0.000203	0.00185	CcSEcCtD
Flurbiprofen—Malaise—Ezetimibe—atherosclerosis	0.000203	0.00185	CcSEcCtD
Flurbiprofen—Arrhythmia—Niacin—atherosclerosis	0.000203	0.00185	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000202	0.00184	CcSEcCtD
Flurbiprofen—Tremor—Simvastatin—atherosclerosis	0.000201	0.00184	CcSEcCtD
Flurbiprofen—Alopecia—Niacin—atherosclerosis	0.0002	0.00183	CcSEcCtD
Flurbiprofen—Chills—Pravastatin—atherosclerosis	0.0002	0.00183	CcSEcCtD
Flurbiprofen—Insomnia—Rosuvastatin—atherosclerosis	0.0002	0.00182	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Simvastatin—atherosclerosis	0.000199	0.00182	CcSEcCtD
Flurbiprofen—Arrhythmia—Pravastatin—atherosclerosis	0.000199	0.00182	CcSEcCtD
Flurbiprofen—Palpitations—Ezetimibe—atherosclerosis	0.000199	0.00182	CcSEcCtD
Flurbiprofen—Paraesthesia—Rosuvastatin—atherosclerosis	0.000199	0.00181	CcSEcCtD
Flurbiprofen—Anaemia—Simvastatin—atherosclerosis	0.000199	0.00181	CcSEcCtD
Flurbiprofen—PTGS2—connective tissue—atherosclerosis	0.000198	0.0189	CbGeAlD
Flurbiprofen—Alopecia—Pravastatin—atherosclerosis	0.000197	0.0018	CcSEcCtD
Flurbiprofen—CYP2C9—cardiovascular system—atherosclerosis	0.000197	0.0188	CbGeAlD
Flurbiprofen—Cough—Ezetimibe—atherosclerosis	0.000197	0.00179	CcSEcCtD
Flurbiprofen—Angioedema—Simvastatin—atherosclerosis	0.000196	0.00179	CcSEcCtD
Flurbiprofen—Myalgia—Lovastatin—atherosclerosis	0.000196	0.00178	CcSEcCtD
Flurbiprofen—ALB—liver—atherosclerosis	0.000195	0.0186	CbGeAlD
Flurbiprofen—Anxiety—Lovastatin—atherosclerosis	0.000195	0.00178	CcSEcCtD
Flurbiprofen—Dyspepsia—Rosuvastatin—atherosclerosis	0.000195	0.00178	CcSEcCtD
Flurbiprofen—Hypertension—Ezetimibe—atherosclerosis	0.000195	0.00177	CcSEcCtD
Flurbiprofen—Flatulence—Niacin—atherosclerosis	0.000194	0.00177	CcSEcCtD
Flurbiprofen—Malaise—Simvastatin—atherosclerosis	0.000194	0.00177	CcSEcCtD
Flurbiprofen—Tension—Niacin—atherosclerosis	0.000194	0.00177	CcSEcCtD
Flurbiprofen—Ketoprofen—CXCL8—atherosclerosis	0.000194	0.0583	CrCbGaD
Flurbiprofen—Discomfort—Lovastatin—atherosclerosis	0.000193	0.00176	CcSEcCtD
Flurbiprofen—Vertigo—Simvastatin—atherosclerosis	0.000193	0.00176	CcSEcCtD
Flurbiprofen—Leukopenia—Simvastatin—atherosclerosis	0.000192	0.00175	CcSEcCtD
Flurbiprofen—Myalgia—Ezetimibe—atherosclerosis	0.000192	0.00175	CcSEcCtD
Flurbiprofen—Nervousness—Niacin—atherosclerosis	0.000192	0.00175	CcSEcCtD
Flurbiprofen—Flatulence—Pravastatin—atherosclerosis	0.000191	0.00175	CcSEcCtD
Flurbiprofen—Dry mouth—Lovastatin—atherosclerosis	0.000191	0.00174	CcSEcCtD
Flurbiprofen—Tension—Pravastatin—atherosclerosis	0.000191	0.00174	CcSEcCtD
Flurbiprofen—Ibuprofen—CXCL8—atherosclerosis	0.000191	0.0574	CrCbGaD
Flurbiprofen—Discomfort—Ezetimibe—atherosclerosis	0.00019	0.00173	CcSEcCtD
Flurbiprofen—Pain—Rosuvastatin—atherosclerosis	0.000189	0.00173	CcSEcCtD
Flurbiprofen—Constipation—Rosuvastatin—atherosclerosis	0.000189	0.00173	CcSEcCtD
Flurbiprofen—ABCC4—liver—atherosclerosis	0.000189	0.018	CbGeAlD
Flurbiprofen—Confusional state—Lovastatin—atherosclerosis	0.000189	0.00172	CcSEcCtD
Flurbiprofen—Nervousness—Pravastatin—atherosclerosis	0.000189	0.00172	CcSEcCtD
Flurbiprofen—Dry mouth—Ezetimibe—atherosclerosis	0.000188	0.00171	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Lovastatin—atherosclerosis	0.000188	0.00171	CcSEcCtD
Flurbiprofen—Infection—Lovastatin—atherosclerosis	0.000186	0.0017	CcSEcCtD
Flurbiprofen—Confusional state—Ezetimibe—atherosclerosis	0.000185	0.00169	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000184	0.00168	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Lovastatin—atherosclerosis	0.000184	0.00167	CcSEcCtD
Flurbiprofen—Myalgia—Simvastatin—atherosclerosis	0.000183	0.00167	CcSEcCtD
Flurbiprofen—Infection—Ezetimibe—atherosclerosis	0.000183	0.00167	CcSEcCtD
Flurbiprofen—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000182	0.00166	CcSEcCtD
Flurbiprofen—Anxiety—Simvastatin—atherosclerosis	0.000182	0.00166	CcSEcCtD
Flurbiprofen—Tremor—Pravastatin—atherosclerosis	0.000182	0.00166	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000181	0.00165	CcSEcCtD
Flurbiprofen—Discomfort—Simvastatin—atherosclerosis	0.000181	0.00165	CcSEcCtD
Flurbiprofen—Angioedema—Niacin—atherosclerosis	0.00018	0.00164	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Pravastatin—atherosclerosis	0.00018	0.00164	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00018	0.00164	CcSEcCtD
Flurbiprofen—PTGS1—cardiovascular system—atherosclerosis	0.00018	0.0172	CbGeAlD
Flurbiprofen—Carprofen—PTGS2—atherosclerosis	0.00018	0.0541	CrCbGaD
Flurbiprofen—Anaemia—Pravastatin—atherosclerosis	0.00018	0.00164	CcSEcCtD
Flurbiprofen—Anorexia—Lovastatin—atherosclerosis	0.000179	0.00163	CcSEcCtD
Flurbiprofen—Angioedema—Pravastatin—atherosclerosis	0.000178	0.00162	CcSEcCtD
Flurbiprofen—Vertigo—Niacin—atherosclerosis	0.000177	0.00162	CcSEcCtD
Flurbiprofen—Syncope—Niacin—atherosclerosis	0.000177	0.00161	CcSEcCtD
Flurbiprofen—Confusional state—Simvastatin—atherosclerosis	0.000177	0.00161	CcSEcCtD
Flurbiprofen—Leukopenia—Niacin—atherosclerosis	0.000177	0.00161	CcSEcCtD
Flurbiprofen—Urticaria—Rosuvastatin—atherosclerosis	0.000176	0.0016	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Simvastatin—atherosclerosis	0.000175	0.0016	CcSEcCtD
Flurbiprofen—Oedema—Simvastatin—atherosclerosis	0.000175	0.0016	CcSEcCtD
Flurbiprofen—Malaise—Pravastatin—atherosclerosis	0.000175	0.0016	CcSEcCtD
Flurbiprofen—Abdominal pain—Rosuvastatin—atherosclerosis	0.000175	0.00159	CcSEcCtD
Flurbiprofen—Vertigo—Pravastatin—atherosclerosis	0.000175	0.00159	CcSEcCtD
Flurbiprofen—Palpitations—Niacin—atherosclerosis	0.000174	0.00159	CcSEcCtD
Flurbiprofen—Infection—Simvastatin—atherosclerosis	0.000174	0.00159	CcSEcCtD
Flurbiprofen—Leukopenia—Pravastatin—atherosclerosis	0.000174	0.00159	CcSEcCtD
Flurbiprofen—Loss of consciousness—Niacin—atherosclerosis	0.000173	0.00158	CcSEcCtD
Flurbiprofen—Cough—Niacin—atherosclerosis	0.000172	0.00157	CcSEcCtD
Flurbiprofen—PTGS2—cardiovascular system—atherosclerosis	0.000172	0.0164	CbGeAlD
Flurbiprofen—Thrombocytopenia—Simvastatin—atherosclerosis	0.000172	0.00157	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000171	0.00156	CcSEcCtD
Flurbiprofen—Insomnia—Lovastatin—atherosclerosis	0.00017	0.00155	CcSEcCtD
Flurbiprofen—Cough—Pravastatin—atherosclerosis	0.00017	0.00155	CcSEcCtD
Flurbiprofen—Paraesthesia—Lovastatin—atherosclerosis	0.000168	0.00154	CcSEcCtD
Flurbiprofen—Myalgia—Niacin—atherosclerosis	0.000168	0.00153	CcSEcCtD
Flurbiprofen—Hypertension—Pravastatin—atherosclerosis	0.000168	0.00153	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000168	0.00153	CcSEcCtD
Flurbiprofen—Anorexia—Simvastatin—atherosclerosis	0.000167	0.00152	CcSEcCtD
Flurbiprofen—Dyspnoea—Lovastatin—atherosclerosis	0.000167	0.00152	CcSEcCtD
Flurbiprofen—Insomnia—Ezetimibe—atherosclerosis	0.000166	0.00152	CcSEcCtD
Flurbiprofen—Myalgia—Pravastatin—atherosclerosis	0.000165	0.00151	CcSEcCtD
Flurbiprofen—Paraesthesia—Ezetimibe—atherosclerosis	0.000165	0.00151	CcSEcCtD
Flurbiprofen—Dyspepsia—Lovastatin—atherosclerosis	0.000165	0.00151	CcSEcCtD
Flurbiprofen—Anxiety—Pravastatin—atherosclerosis	0.000165	0.0015	CcSEcCtD
Flurbiprofen—Dry mouth—Niacin—atherosclerosis	0.000164	0.0015	CcSEcCtD
Flurbiprofen—Dyspnoea—Ezetimibe—atherosclerosis	0.000164	0.0015	CcSEcCtD
Flurbiprofen—Discomfort—Pravastatin—atherosclerosis	0.000163	0.00149	CcSEcCtD
Flurbiprofen—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000163	0.00149	CcSEcCtD
Flurbiprofen—Decreased appetite—Lovastatin—atherosclerosis	0.000163	0.00149	CcSEcCtD
Flurbiprofen—Dyspepsia—Ezetimibe—atherosclerosis	0.000162	0.00148	CcSEcCtD
Flurbiprofen—Oedema—Niacin—atherosclerosis	0.000161	0.00147	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Niacin—atherosclerosis	0.000161	0.00147	CcSEcCtD
Flurbiprofen—Pain—Lovastatin—atherosclerosis	0.00016	0.00146	CcSEcCtD
Flurbiprofen—Constipation—Lovastatin—atherosclerosis	0.00016	0.00146	CcSEcCtD
Flurbiprofen—Confusional state—Pravastatin—atherosclerosis	0.00016	0.00146	CcSEcCtD
Flurbiprofen—Decreased appetite—Ezetimibe—atherosclerosis	0.00016	0.00146	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00016	0.00146	CcSEcCtD
Flurbiprofen—PTGS1—adipose tissue—atherosclerosis	0.000159	0.0151	CbGeAlD
Flurbiprofen—Asthenia—Rosuvastatin—atherosclerosis	0.000159	0.00145	CcSEcCtD
Flurbiprofen—Insomnia—Simvastatin—atherosclerosis	0.000159	0.00145	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Pravastatin—atherosclerosis	0.000159	0.00145	CcSEcCtD
Flurbiprofen—Oedema—Pravastatin—atherosclerosis	0.000159	0.00145	CcSEcCtD
Flurbiprofen—Shock—Niacin—atherosclerosis	0.000158	0.00144	CcSEcCtD
Flurbiprofen—Infection—Pravastatin—atherosclerosis	0.000158	0.00144	CcSEcCtD
Flurbiprofen—Paraesthesia—Simvastatin—atherosclerosis	0.000158	0.00144	CcSEcCtD
Flurbiprofen—Pain—Ezetimibe—atherosclerosis	0.000157	0.00143	CcSEcCtD
Flurbiprofen—Constipation—Ezetimibe—atherosclerosis	0.000157	0.00143	CcSEcCtD
Flurbiprofen—Tachycardia—Niacin—atherosclerosis	0.000157	0.00143	CcSEcCtD
Flurbiprofen—Pruritus—Rosuvastatin—atherosclerosis	0.000157	0.00143	CcSEcCtD
Flurbiprofen—Dyspnoea—Simvastatin—atherosclerosis	0.000156	0.00143	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Niacin—atherosclerosis	0.000156	0.00142	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Pravastatin—atherosclerosis	0.000155	0.00142	CcSEcCtD
Flurbiprofen—Feeling abnormal—Lovastatin—atherosclerosis	0.000155	0.00141	CcSEcCtD
Flurbiprofen—Dyspepsia—Simvastatin—atherosclerosis	0.000154	0.00141	CcSEcCtD
Flurbiprofen—Anorexia—Niacin—atherosclerosis	0.000154	0.0014	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000153	0.0014	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Pravastatin—atherosclerosis	0.000153	0.0014	CcSEcCtD
Flurbiprofen—Decreased appetite—Simvastatin—atherosclerosis	0.000152	0.00139	CcSEcCtD
Flurbiprofen—PTGS2—adipose tissue—atherosclerosis	0.000152	0.0145	CbGeAlD
Flurbiprofen—Feeling abnormal—Ezetimibe—atherosclerosis	0.000152	0.00138	CcSEcCtD
Flurbiprofen—Diarrhoea—Rosuvastatin—atherosclerosis	0.000151	0.00138	CcSEcCtD
Flurbiprofen—Anorexia—Pravastatin—atherosclerosis	0.000151	0.00138	CcSEcCtD
Flurbiprofen—Hypotension—Niacin—atherosclerosis	0.000151	0.00137	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00015	0.00137	CcSEcCtD
Flurbiprofen—Pain—Simvastatin—atherosclerosis	0.00015	0.00137	CcSEcCtD
Flurbiprofen—Constipation—Simvastatin—atherosclerosis	0.00015	0.00137	CcSEcCtD
Flurbiprofen—Urticaria—Lovastatin—atherosclerosis	0.000149	0.00136	CcSEcCtD
Flurbiprofen—Body temperature increased—Lovastatin—atherosclerosis	0.000148	0.00135	CcSEcCtD
Flurbiprofen—Abdominal pain—Lovastatin—atherosclerosis	0.000148	0.00135	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000147	0.00134	CcSEcCtD
Flurbiprofen—Tiaprofenic acid—PTGS2—atherosclerosis	0.000146	0.0441	CrCbGaD
Flurbiprofen—Dizziness—Rosuvastatin—atherosclerosis	0.000146	0.00133	CcSEcCtD
Flurbiprofen—Urticaria—Ezetimibe—atherosclerosis	0.000146	0.00133	CcSEcCtD
Flurbiprofen—Insomnia—Niacin—atherosclerosis	0.000146	0.00133	CcSEcCtD
Flurbiprofen—Abdominal pain—Ezetimibe—atherosclerosis	0.000145	0.00133	CcSEcCtD
Flurbiprofen—Body temperature increased—Ezetimibe—atherosclerosis	0.000145	0.00133	CcSEcCtD
Flurbiprofen—Paraesthesia—Niacin—atherosclerosis	0.000145	0.00132	CcSEcCtD
Flurbiprofen—Feeling abnormal—Simvastatin—atherosclerosis	0.000145	0.00132	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000144	0.00132	CcSEcCtD
Flurbiprofen—Dyspnoea—Niacin—atherosclerosis	0.000144	0.00131	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000143	0.00131	CcSEcCtD
Flurbiprofen—Insomnia—Pravastatin—atherosclerosis	0.000143	0.00131	CcSEcCtD
Flurbiprofen—Somnolence—Niacin—atherosclerosis	0.000143	0.00131	CcSEcCtD
Flurbiprofen—Paraesthesia—Pravastatin—atherosclerosis	0.000142	0.0013	CcSEcCtD
Flurbiprofen—Dyspepsia—Niacin—atherosclerosis	0.000142	0.00129	CcSEcCtD
Flurbiprofen—Dyspnoea—Pravastatin—atherosclerosis	0.000141	0.00129	CcSEcCtD
Flurbiprofen—Decreased appetite—Niacin—atherosclerosis	0.00014	0.00128	CcSEcCtD
Flurbiprofen—Dyspepsia—Pravastatin—atherosclerosis	0.00014	0.00127	CcSEcCtD
Flurbiprofen—Rash—Rosuvastatin—atherosclerosis	0.00014	0.00127	CcSEcCtD
Flurbiprofen—Dermatitis—Rosuvastatin—atherosclerosis	0.000139	0.00127	CcSEcCtD
Flurbiprofen—Urticaria—Simvastatin—atherosclerosis	0.000139	0.00127	CcSEcCtD
Flurbiprofen—Abdominal pain—Simvastatin—atherosclerosis	0.000139	0.00126	CcSEcCtD
Flurbiprofen—Body temperature increased—Simvastatin—atherosclerosis	0.000139	0.00126	CcSEcCtD
Flurbiprofen—Headache—Rosuvastatin—atherosclerosis	0.000139	0.00126	CcSEcCtD
Flurbiprofen—Hypersensitivity—Lovastatin—atherosclerosis	0.000138	0.00126	CcSEcCtD
Flurbiprofen—Decreased appetite—Pravastatin—atherosclerosis	0.000138	0.00126	CcSEcCtD
Flurbiprofen—Pain—Niacin—atherosclerosis	0.000138	0.00126	CcSEcCtD
Flurbiprofen—Pain—Pravastatin—atherosclerosis	0.000136	0.00124	CcSEcCtD
Flurbiprofen—Constipation—Pravastatin—atherosclerosis	0.000136	0.00124	CcSEcCtD
Flurbiprofen—Hypersensitivity—Ezetimibe—atherosclerosis	0.000136	0.00124	CcSEcCtD
Flurbiprofen—Asthenia—Lovastatin—atherosclerosis	0.000135	0.00123	CcSEcCtD
Flurbiprofen—Fenbufen—PTGS2—atherosclerosis	0.000133	0.0401	CrCbGaD
Flurbiprofen—Pruritus—Lovastatin—atherosclerosis	0.000133	0.00121	CcSEcCtD
Flurbiprofen—Asthenia—Ezetimibe—atherosclerosis	0.000132	0.0012	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Niacin—atherosclerosis	0.000132	0.0012	CcSEcCtD
Flurbiprofen—Ibuprofen—PPARG—atherosclerosis	0.000132	0.0397	CrCbGaD
Flurbiprofen—Nausea—Rosuvastatin—atherosclerosis	0.000131	0.0012	CcSEcCtD
Flurbiprofen—Feeling abnormal—Pravastatin—atherosclerosis	0.000131	0.00119	CcSEcCtD
Flurbiprofen—Pruritus—Ezetimibe—atherosclerosis	0.00013	0.00119	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00013	0.00118	CcSEcCtD
Flurbiprofen—Hypersensitivity—Simvastatin—atherosclerosis	0.000129	0.00118	CcSEcCtD
Flurbiprofen—Diarrhoea—Lovastatin—atherosclerosis	0.000128	0.00117	CcSEcCtD
Flurbiprofen—Diflunisal—PTGS2—atherosclerosis	0.000128	0.0386	CrCbGaD
Flurbiprofen—Urticaria—Niacin—atherosclerosis	0.000128	0.00117	CcSEcCtD
Flurbiprofen—Abdominal pain—Niacin—atherosclerosis	0.000127	0.00116	CcSEcCtD
Flurbiprofen—Body temperature increased—Niacin—atherosclerosis	0.000127	0.00116	CcSEcCtD
Flurbiprofen—Urticaria—Pravastatin—atherosclerosis	0.000126	0.00115	CcSEcCtD
Flurbiprofen—Asthenia—Simvastatin—atherosclerosis	0.000126	0.00115	CcSEcCtD
Flurbiprofen—Diarrhoea—Ezetimibe—atherosclerosis	0.000126	0.00115	CcSEcCtD
Flurbiprofen—Body temperature increased—Pravastatin—atherosclerosis	0.000125	0.00114	CcSEcCtD
Flurbiprofen—Abdominal pain—Pravastatin—atherosclerosis	0.000125	0.00114	CcSEcCtD
Flurbiprofen—Pruritus—Simvastatin—atherosclerosis	0.000124	0.00113	CcSEcCtD
Flurbiprofen—Dizziness—Lovastatin—atherosclerosis	0.000124	0.00113	CcSEcCtD
Flurbiprofen—CYP2C9—liver—atherosclerosis	0.000122	0.0116	CbGeAlD
Flurbiprofen—Dizziness—Ezetimibe—atherosclerosis	0.000122	0.00111	CcSEcCtD
Flurbiprofen—Diarrhoea—Simvastatin—atherosclerosis	0.00012	0.00109	CcSEcCtD
Flurbiprofen—Vomiting—Lovastatin—atherosclerosis	0.000119	0.00109	CcSEcCtD
Flurbiprofen—Hypersensitivity—Niacin—atherosclerosis	0.000119	0.00108	CcSEcCtD
Flurbiprofen—Rash—Lovastatin—atherosclerosis	0.000118	0.00108	CcSEcCtD
Flurbiprofen—Dermatitis—Lovastatin—atherosclerosis	0.000118	0.00108	CcSEcCtD
Flurbiprofen—Headache—Lovastatin—atherosclerosis	0.000117	0.00107	CcSEcCtD
Flurbiprofen—Vomiting—Ezetimibe—atherosclerosis	0.000117	0.00107	CcSEcCtD
Flurbiprofen—Hypersensitivity—Pravastatin—atherosclerosis	0.000117	0.00107	CcSEcCtD
Flurbiprofen—Dizziness—Simvastatin—atherosclerosis	0.000116	0.00106	CcSEcCtD
Flurbiprofen—Rash—Ezetimibe—atherosclerosis	0.000116	0.00106	CcSEcCtD
Flurbiprofen—Dermatitis—Ezetimibe—atherosclerosis	0.000116	0.00106	CcSEcCtD
Flurbiprofen—Oxaprozin—PTGS2—atherosclerosis	0.000116	0.0349	CrCbGaD
Flurbiprofen—Salsalate—PTGS2—atherosclerosis	0.000116	0.0349	CrCbGaD
Flurbiprofen—Asthenia—Niacin—atherosclerosis	0.000116	0.00105	CcSEcCtD
Flurbiprofen—Headache—Ezetimibe—atherosclerosis	0.000115	0.00105	CcSEcCtD
Flurbiprofen—Diflunisal—ALB—atherosclerosis	0.000114	0.0344	CrCbGaD
Flurbiprofen—Pruritus—Niacin—atherosclerosis	0.000114	0.00104	CcSEcCtD
Flurbiprofen—Asthenia—Pravastatin—atherosclerosis	0.000114	0.00104	CcSEcCtD
Flurbiprofen—Pruritus—Pravastatin—atherosclerosis	0.000112	0.00102	CcSEcCtD
Flurbiprofen—Vomiting—Simvastatin—atherosclerosis	0.000112	0.00102	CcSEcCtD
Flurbiprofen—Nausea—Lovastatin—atherosclerosis	0.000111	0.00102	CcSEcCtD
Flurbiprofen—Suprofen—PTGS2—atherosclerosis	0.000111	0.0334	CrCbGaD
Flurbiprofen—Rash—Simvastatin—atherosclerosis	0.000111	0.00101	CcSEcCtD
Flurbiprofen—Dermatitis—Simvastatin—atherosclerosis	0.000111	0.00101	CcSEcCtD
Flurbiprofen—Diarrhoea—Niacin—atherosclerosis	0.00011	0.001	CcSEcCtD
Flurbiprofen—Headache—Simvastatin—atherosclerosis	0.00011	0.001	CcSEcCtD
Flurbiprofen—Nausea—Ezetimibe—atherosclerosis	0.000109	0.000996	CcSEcCtD
Flurbiprofen—Diarrhoea—Pravastatin—atherosclerosis	0.000109	0.000989	CcSEcCtD
Flurbiprofen—Dizziness—Niacin—atherosclerosis	0.000107	0.000971	CcSEcCtD
Flurbiprofen—PTGS2—liver—atherosclerosis	0.000106	0.0102	CbGeAlD
Flurbiprofen—Dizziness—Pravastatin—atherosclerosis	0.000105	0.000956	CcSEcCtD
Flurbiprofen—Nausea—Simvastatin—atherosclerosis	0.000104	0.00095	CcSEcCtD
Flurbiprofen—Vomiting—Niacin—atherosclerosis	0.000102	0.000934	CcSEcCtD
Flurbiprofen—Rash—Niacin—atherosclerosis	0.000102	0.000926	CcSEcCtD
Flurbiprofen—Dermatitis—Niacin—atherosclerosis	0.000101	0.000925	CcSEcCtD
Flurbiprofen—Headache—Niacin—atherosclerosis	0.000101	0.00092	CcSEcCtD
Flurbiprofen—Vomiting—Pravastatin—atherosclerosis	0.000101	0.000919	CcSEcCtD
Flurbiprofen—Rash—Pravastatin—atherosclerosis	0.0001	0.000912	CcSEcCtD
Flurbiprofen—Dermatitis—Pravastatin—atherosclerosis	9.99e-05	0.000911	CcSEcCtD
Flurbiprofen—Headache—Pravastatin—atherosclerosis	9.94e-05	0.000906	CcSEcCtD
Flurbiprofen—Nausea—Niacin—atherosclerosis	9.57e-05	0.000872	CcSEcCtD
Flurbiprofen—Fenoprofen—PTGS2—atherosclerosis	9.57e-05	0.0288	CrCbGaD
Flurbiprofen—Nausea—Pravastatin—atherosclerosis	9.42e-05	0.000859	CcSEcCtD
Flurbiprofen—Mefenamic acid—PTGS2—atherosclerosis	8.87e-05	0.0267	CrCbGaD
Flurbiprofen—Naproxen—PTGS2—atherosclerosis	8.71e-05	0.0262	CrCbGaD
Flurbiprofen—Fenoprofen—ALB—atherosclerosis	8.52e-05	0.0257	CrCbGaD
Flurbiprofen—Naproxen—ALB—atherosclerosis	7.76e-05	0.0234	CrCbGaD
Flurbiprofen—Warfarin—ALB—atherosclerosis	6.52e-05	0.0196	CrCbGaD
Flurbiprofen—Ketoprofen—PTGS2—atherosclerosis	5.65e-05	0.017	CrCbGaD
Flurbiprofen—Ibuprofen—PTGS2—atherosclerosis	5.56e-05	0.0167	CrCbGaD
Flurbiprofen—Ketoprofen—ALB—atherosclerosis	5.03e-05	0.0152	CrCbGaD
Flurbiprofen—Ibuprofen—ALB—atherosclerosis	4.95e-05	0.0149	CrCbGaD
Flurbiprofen—Diazepam—ALB—atherosclerosis	3.03e-05	0.00914	CrCbGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—VEGFA—atherosclerosis	8.76e-06	0.000111	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—APOA2—atherosclerosis	8.75e-06	0.000111	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PLA2G2A—atherosclerosis	8.75e-06	0.000111	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ALOX5AP—atherosclerosis	8.75e-06	0.000111	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ALOX15—atherosclerosis	8.75e-06	0.000111	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PDGFB—atherosclerosis	8.75e-06	0.000111	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—MMP1—atherosclerosis	8.65e-06	0.00011	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ABCG5—atherosclerosis	8.64e-06	0.000109	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	8.63e-06	0.000109	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—MTHFR—atherosclerosis	8.56e-06	0.000108	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CYBA—atherosclerosis	8.5e-06	0.000108	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	8.5e-06	0.000108	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—FABP4—atherosclerosis	8.48e-06	0.000107	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—LCAT—atherosclerosis	8.48e-06	0.000107	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PIK3CG—atherosclerosis	8.46e-06	0.000107	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—HMOX1—atherosclerosis	8.45e-06	0.000107	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—HMOX1—atherosclerosis	8.45e-06	0.000107	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PPARA—atherosclerosis	8.4e-06	0.000106	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—LPA—atherosclerosis	8.35e-06	0.000106	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PARP1—atherosclerosis	8.32e-06	0.000105	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—APOA4—atherosclerosis	8.32e-06	0.000105	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—CAV1—atherosclerosis	8.29e-06	0.000105	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	8.29e-06	0.000105	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—APOA1—atherosclerosis	8.27e-06	0.000105	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—NAMPT—atherosclerosis	8.25e-06	0.000104	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.2e-06	0.000104	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—LIPC—atherosclerosis	8.2e-06	0.000104	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CYP7A1—atherosclerosis	8.17e-06	0.000104	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PPARG—atherosclerosis	8.17e-06	0.000103	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—APOC3—atherosclerosis	8.14e-06	0.000103	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—AGT—atherosclerosis	8.14e-06	0.000103	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.12e-06	0.000103	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—LDLR—atherosclerosis	8.1e-06	0.000103	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—APOB—atherosclerosis	8.09e-06	0.000103	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—APOB—atherosclerosis	8.09e-06	0.000103	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—BGN—atherosclerosis	8.08e-06	0.000102	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	8.04e-06	0.000102	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—ABCA1—atherosclerosis	8.03e-06	0.000102	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	8.03e-06	0.000102	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—INS—atherosclerosis	8.01e-06	0.000101	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—APOA5—atherosclerosis	8e-06	0.000101	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—APOE—atherosclerosis	7.97e-06	0.000101	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CETP—atherosclerosis	7.91e-06	0.0001	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—CAV1—atherosclerosis	7.9e-06	0.0001	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—F2—atherosclerosis	7.89e-06	0.0001	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—APOA1—atherosclerosis	7.88e-06	9.98e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—GSTM1—atherosclerosis	7.87e-06	9.98e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—GSTM1—atherosclerosis	7.87e-06	9.98e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—NOS2—atherosclerosis	7.8e-06	9.88e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	7.79e-06	9.87e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	7.77e-06	9.85e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	7.76e-06	9.84e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—LPL—atherosclerosis	7.73e-06	9.79e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—LPL—atherosclerosis	7.73e-06	9.79e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PLA2G1B—atherosclerosis	7.7e-06	9.76e-05	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—PPARA—atherosclerosis	7.63e-06	9.67e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	7.62e-06	9.65e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—SCARB1—atherosclerosis	7.57e-06	9.59e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CYP27A1—atherosclerosis	7.55e-06	9.57e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PIK3CG—atherosclerosis	7.55e-06	9.57e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	7.55e-06	9.56e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—GPX1—atherosclerosis	7.54e-06	9.55e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—GPX1—atherosclerosis	7.54e-06	9.55e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	7.53e-06	9.54e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ALOX5—atherosclerosis	7.44e-06	9.43e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	7.44e-06	9.42e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.37e-06	9.34e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—CD36—atherosclerosis	7.34e-06	9.3e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—ALB—atherosclerosis	7.34e-06	9.3e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—CD36—atherosclerosis	7.34e-06	9.3e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	7.26e-06	9.19e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PIK3CG—atherosclerosis	7.19e-06	9.12e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	7.16e-06	9.07e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ALOX15—atherosclerosis	7.16e-06	9.07e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	7.16e-06	9.07e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—APOA2—atherosclerosis	7.16e-06	9.07e-05	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	7.16e-06	9.07e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—HMGCR—atherosclerosis	7.15e-06	9.06e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ABCG5—atherosclerosis	7.07e-06	8.96e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	7.07e-06	8.95e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—NOS3—atherosclerosis	7.02e-06	8.9e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—MTHFR—atherosclerosis	6.96e-06	8.82e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—MTHFR—atherosclerosis	6.96e-06	8.82e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PPARG—atherosclerosis	6.94e-06	8.8e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—IGF1—atherosclerosis	6.91e-06	8.76e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—HMOX1—atherosclerosis	6.89e-06	8.73e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	6.87e-06	8.71e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—LPA—atherosclerosis	6.83e-06	8.66e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PPARA—atherosclerosis	6.83e-06	8.65e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PPARA—atherosclerosis	6.83e-06	8.65e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—INS—atherosclerosis	6.81e-06	8.63e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—NAMPT—atherosclerosis	6.67e-06	8.45e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	6.63e-06	8.4e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—LIPC—atherosclerosis	6.63e-06	8.4e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—BGN—atherosclerosis	6.62e-06	8.38e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—AGT—atherosclerosis	6.61e-06	8.38e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—AGT—atherosclerosis	6.61e-06	8.38e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—APOB—atherosclerosis	6.6e-06	8.36e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—APOC3—atherosclerosis	6.59e-06	8.35e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	6.57e-06	8.32e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—SERPINE1—atherosclerosis	6.56e-06	8.32e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—APOA5—atherosclerosis	6.55e-06	8.3e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—LDLR—atherosclerosis	6.55e-06	8.3e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—APOE—atherosclerosis	6.48e-06	8.21e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—APOE—atherosclerosis	6.48e-06	8.21e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PTGS2—atherosclerosis	6.42e-06	8.14e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—GSTM1—atherosclerosis	6.42e-06	8.13e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—CAV1—atherosclerosis	6.42e-06	8.13e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—CAV1—atherosclerosis	6.42e-06	8.13e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—APOA1—atherosclerosis	6.4e-06	8.11e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—APOA1—atherosclerosis	6.4e-06	8.11e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CETP—atherosclerosis	6.4e-06	8.11e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—ABCA1—atherosclerosis	6.37e-06	8.08e-05	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—AKT1—atherosclerosis	6.37e-06	8.07e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	6.36e-06	8.06e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	6.3e-06	7.99e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—LPL—atherosclerosis	6.3e-06	7.98e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—NOS3—atherosclerosis	6.27e-06	7.94e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—APOB—atherosclerosis	6.25e-06	7.92e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—ALB—atherosclerosis	6.24e-06	7.91e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	6.23e-06	7.9e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	6.18e-06	7.83e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	6.16e-06	7.81e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—GPX1—atherosclerosis	6.15e-06	7.79e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—SCARB1—atherosclerosis	6.13e-06	7.76e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ALOX5—atherosclerosis	6.09e-06	7.71e-05	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—AKT1—atherosclerosis	6.03e-06	7.64e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CD36—atherosclerosis	5.99e-06	7.58e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—NOS3—atherosclerosis	5.97e-06	7.57e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—LPL—atherosclerosis	5.97e-06	7.57e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PIK3CG—atherosclerosis	5.85e-06	7.41e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PIK3CG—atherosclerosis	5.85e-06	7.41e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PRKCG—atherosclerosis	5.81e-06	7.36e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—HMGCR—atherosclerosis	5.79e-06	7.33e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—MTHFR—atherosclerosis	5.67e-06	7.19e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PPARG—atherosclerosis	5.64e-06	7.15e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PPARG—atherosclerosis	5.64e-06	7.15e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	5.63e-06	7.13e-05	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	5.59e-06	7.08e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PPARA—atherosclerosis	5.57e-06	7.05e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—INS—atherosclerosis	5.53e-06	7.01e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—INS—atherosclerosis	5.53e-06	7.01e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—HMOX1—atherosclerosis	5.47e-06	6.93e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PTGS2—atherosclerosis	5.46e-06	6.92e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—NAMPT—atherosclerosis	5.46e-06	6.92e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.43e-06	6.88e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—LIPC—atherosclerosis	5.43e-06	6.88e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—APOC3—atherosclerosis	5.39e-06	6.83e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—AGT—atherosclerosis	5.39e-06	6.83e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—MTHFR—atherosclerosis	5.38e-06	6.81e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—LDLR—atherosclerosis	5.36e-06	6.79e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—APOE—atherosclerosis	5.28e-06	6.69e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—APOB—atherosclerosis	5.24e-06	6.64e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CETP—atherosclerosis	5.24e-06	6.63e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PDGFB—atherosclerosis	5.23e-06	6.63e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CAV1—atherosclerosis	5.23e-06	6.63e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—APOA1—atherosclerosis	5.22e-06	6.61e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.22e-06	6.61e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ABCA1—atherosclerosis	5.16e-06	6.53e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—GSTM1—atherosclerosis	5.1e-06	6.46e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—ALB—atherosclerosis	5.07e-06	6.43e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—ALB—atherosclerosis	5.07e-06	6.43e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—SCARB1—atherosclerosis	5.01e-06	6.35e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—APOE—atherosclerosis	5.01e-06	6.34e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—LPL—atherosclerosis	5e-06	6.34e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CAV1—atherosclerosis	4.96e-06	6.28e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—APOA1—atherosclerosis	4.95e-06	6.27e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.88e-06	6.19e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—GPX1—atherosclerosis	4.88e-06	6.18e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—NOS3—atherosclerosis	4.85e-06	6.15e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—NOS3—atherosclerosis	4.85e-06	6.15e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PIK3CG—atherosclerosis	4.77e-06	6.04e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CD36—atherosclerosis	4.75e-06	6.02e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—HMGCR—atherosclerosis	4.74e-06	6e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—NOS2—atherosclerosis	4.66e-06	5.91e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PPARG—atherosclerosis	4.6e-06	5.83e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—VEGFA—atherosclerosis	4.52e-06	5.72e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—INS—atherosclerosis	4.51e-06	5.72e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—MTHFR—atherosclerosis	4.5e-06	5.71e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PTGS2—atherosclerosis	4.44e-06	5.62e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PTGS2—atherosclerosis	4.44e-06	5.62e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—HMOX1—atherosclerosis	4.42e-06	5.61e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PPARA—atherosclerosis	4.42e-06	5.6e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—AGT—atherosclerosis	4.28e-06	5.42e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—INS—atherosclerosis	4.28e-06	5.42e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.27e-06	5.41e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—MAPK3—atherosclerosis	4.27e-06	5.41e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—APOB—atherosclerosis	4.24e-06	5.37e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ABCA1—atherosclerosis	4.22e-06	5.35e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—APOE—atherosclerosis	4.19e-06	5.31e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CAV1—atherosclerosis	4.15e-06	5.26e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—APOA1—atherosclerosis	4.14e-06	5.25e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—TGFB1—atherosclerosis	4.14e-06	5.25e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—ALB—atherosclerosis	4.14e-06	5.24e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GSTM1—atherosclerosis	4.12e-06	5.22e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—LPL—atherosclerosis	4.05e-06	5.13e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—NOS3—atherosclerosis	3.96e-06	5.01e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GPX1—atherosclerosis	3.95e-06	5e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—SERPINE1—atherosclerosis	3.93e-06	4.98e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CD36—atherosclerosis	3.84e-06	4.87e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PIK3CG—atherosclerosis	3.78e-06	4.79e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—NOS3—atherosclerosis	3.75e-06	4.75e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PPARG—atherosclerosis	3.65e-06	4.63e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—MTHFR—atherosclerosis	3.64e-06	4.62e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—HMOX1—atherosclerosis	3.62e-06	4.59e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PTGS2—atherosclerosis	3.62e-06	4.58e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—INS—atherosclerosis	3.58e-06	4.54e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PPARA—atherosclerosis	3.57e-06	4.53e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—APOB—atherosclerosis	3.47e-06	4.39e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—AGT—atherosclerosis	3.46e-06	4.39e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—APOE—atherosclerosis	3.39e-06	4.3e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTM1—atherosclerosis	3.37e-06	4.28e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CAV1—atherosclerosis	3.36e-06	4.26e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—APOA1—atherosclerosis	3.35e-06	4.25e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—LPL—atherosclerosis	3.31e-06	4.2e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—ALB—atherosclerosis	3.28e-06	4.16e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GPX1—atherosclerosis	3.23e-06	4.09e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—AKT1—atherosclerosis	3.23e-06	4.09e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CD36—atherosclerosis	3.15e-06	3.99e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—NOS3—atherosclerosis	3.14e-06	3.98e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PIK3CG—atherosclerosis	3.06e-06	3.88e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—MTHFR—atherosclerosis	2.98e-06	3.78e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PPARG—atherosclerosis	2.95e-06	3.74e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PPARA—atherosclerosis	2.93e-06	3.71e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—INS—atherosclerosis	2.9e-06	3.67e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—AKT1—atherosclerosis	2.88e-06	3.65e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—AGT—atherosclerosis	2.83e-06	3.59e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—APOE—atherosclerosis	2.78e-06	3.52e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CAV1—atherosclerosis	2.75e-06	3.49e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—AKT1—atherosclerosis	2.75e-06	3.48e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—APOA1—atherosclerosis	2.74e-06	3.48e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—STAT3—atherosclerosis	2.68e-06	3.39e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—MAPK3—atherosclerosis	2.56e-06	3.24e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—NOS3—atherosclerosis	2.54e-06	3.22e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PIK3CG—atherosclerosis	2.51e-06	3.17e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—TGFB1—atherosclerosis	2.48e-06	3.14e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PPARG—atherosclerosis	2.42e-06	3.06e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—INS—atherosclerosis	2.37e-06	3e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PTGS2—atherosclerosis	2.32e-06	2.94e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—AKT1—atherosclerosis	2.23e-06	2.83e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—AKT1—atherosclerosis	2.23e-06	2.83e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ALB—atherosclerosis	2.17e-06	2.75e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—NOS3—atherosclerosis	2.08e-06	2.64e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PTGS2—atherosclerosis	1.9e-06	2.41e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—IL6—atherosclerosis	1.87e-06	2.37e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—AKT1—atherosclerosis	1.82e-06	2.3e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—AKT1—atherosclerosis	1.72e-06	2.18e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—AKT1—atherosclerosis	1.44e-06	1.83e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—AKT1—atherosclerosis	1.17e-06	1.48e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—AKT1—atherosclerosis	9.56e-07	1.21e-05	CbGpPWpGaD
